| Eisenführ, Günther |
n. a. |
Eisenführ Speiser Patentanwälte Rechtsanwälte PartGmbB |
Germany |
| Eisenhaber, Frank |
n. a. |
Boehringer Ingelheim (Group) |
Austria |
| Eistetter, Harald (Rhecadis 201201– Managing Director + Co-Founder before Biognosys CBO + EvalueScience + Indivumed) |
Managing Director |
Rhecadis GmbH |
Germany |
| El Khoury, Mohammad (Qiagen 201610 President + Head of Commercial Operations EMEA) |
Chief Commercial Officer (CCO) |
Qiagen (Group) |
Germany |
| Elbers, Knut (Boehringer Ingelheim 201204 Investment Manager + Director Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Elbl, Gabriele (MorphoSys 201312– Head of Regulatory Affairs before Wilex + EMA + Sanofi Winthrop) |
Regulatory Affairs Manager |
MorphoSys (Group) |
Germany |
| Elbraechter, Hanno (DKSH 201804 Head Business Unit Technology) |
President/Director/Head Business Group/Unit/Division |
DKSH (Group) |
Switzerland |
| Eletr, Sam (Third Wave Technologies 200504 Director) |
Board member |
Hologic (Group) |
United States (USA) |
| Elff, Manfred (Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung 201009 Managing Director) |
Managing Director |
Niedersächsisches Zentrum für Biomedizintechnik und Implantatforschung (NZ-BMT) |
|
| Elger, Daniel (Genkyotec 201406– CFO + Chief Development Officer before e-Therapeutics plc + Antisoma) |
Chief Financial Officer (CFO) |
Genkyotex (Group) |
Switzerland |
| Ellam, David (Silence Therapeutics 201607– CFO before BioMarin + Plethora Solutions + Ark Therapeutics) |
Chief Financial Officer (CFO) |
Silence Therapeutics (Group) |
United Kingdom (GB) |
| Elliott, Mary-Jane (Consilium SC 201307– Managing Partner + Co-founder before M:Communications) |
Public Relations Manager / Investor Relations Manager |
Consilium Strategic Communications Ltd. (CSC) |
United Kingdom (GB) |
| Ellmann, Felix (M.M. Warburg 200909 Managing Director + Analyst SES Research GmbH) |
Analyst (Financial / Industry) |
M.M. Warburg (Group) |
Germany |
| Ellrich, Jens (Sapiens CMO) |
Consultant (economic/technology) |
Medtronic (Group) |
Netherlands |
| Elssner, Thomas (Bruker Corp 201708 Bio-Dection Manager at Bruker Detection division) |
n. a. |
Bruker Corporation (Group) |
Germany |
| Emler, Stefan (SmartGene 201108 CEO) |
Chief Executive Officer (CEO) |
SmartGene (Group) |
Switzerland |
| Emmenegger, Andreas (Molecular Partners 201603 CFO) |
Chief Financial Officer (CFO) |
Molecular Partners AG (SIX: MOLN) |
Switzerland |
| Emmerich, Niels (AbbVie 201504– Global Head Search + Evaluation Oncology joined 201110 before Biopheresis + Immatics) |
Chief Operating Officer (COO) |
Immatics (Group) |
Germany |
| Emmerich, Ralf (Aurelia Private Equity 200201–) |
n. a. |
Aurelia (Group) |
Germany |
| Emmerich, Wolf-Dieter (Netzsch Instruments) |
Consultant (economic/technology) |
Netzsch (Group) |
Germany |
| Emmick, Jeff (Lilly 201706 VP Product Development at Lilly Diabetes) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Endress, Klaus (Endress+Hauser 201309 CEO) |
Chief Executive Officer (CEO) |
Endress+Hauser (Group) |
Switzerland |
| Engel, Jürgen (Æterna Zentaris 200504) |
Chief Operating Officer (COO) |
Æterna Zentaris (Group) |
Canada |
| Engel, Klaus (Evonik 201112 Chairman of Executive Board) |
Chief Executive Officer (CEO) |
Evonik (Group) |
Germany |
| Engel, Sven (Amantec GmbH 201108 Managing Director) |
Managing Director |
Sacura GmbH |
Germany |
| Engeland, Birgit (AltonaBiotec 200810) |
n. a. |
AltonaBiotec AG |
Germany |
| Engelen, Julie (SGS 201802 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Engelhard, Markus (Boehmert & Boehmert 200501–200809–) |
Patent Attorney |
Boehmert & Boehmert (Patentanwälte) (Group) |
Germany |
| Engeser, Marianne (Uni Bonn 200910 Head Div of Mass Spectrometry) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of Bonn (Rheinsche Friedrich-Wilhelms-Universität Bonn) |
Germany |
| Enghild, Jan J. (Aarhus Univ 201106 Professor Laboratory for Proteome Analysis and Protein Characterisation) |
Professor |
Aarhus University |
Denmark |
| Enghofer, Erich (4SC 201406– EVP Oncology + Haematology before Bayer Healthcare) |
President/Director/Head Business Group/Unit/Division |
4SC (Group) |
Germany |
| England, Claire (Scott Partnership 201408 at Phoenix MarCom) |
Public Relations Manager / Investor Relations Manager |
Scott Partnership (Scott PR) (Group) |
United Kingdom (GB) |
| Englbrecht, Claudia (BIO Deutschland 2013 Public Relations Manager) |
public/private partnership |
BIO Deutschland e. V. |
Germany |
| Engleman, Katie (1AB Media 201903 before Pure Communications) |
Public Relations Manager / Investor Relations Manager |
1AB Media |
United States (USA) |
| Enns, Timothy L. (KineMed 201401– Chief Investor + Media Relations Officer before Astex/SuperGen) |
Public Relations Manager / Investor Relations Manager |
KineMed Inc. |
United States (USA) |
| Enyedy, Mark J. (ImmunoGen 201705 CEO before Genzyme 200803 President Genzyme Oncology) |
Chief Executive Officer (CEO) |
ImmunoGen Inc. (Nasdaq: IMGN) |
United States (USA) |
| Enzelberger, Markus (MorphoSys 201711– CSO jined 2002 before California Institue of Technology) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
MorphoSys (Group) |
Germany |
| Epping-Jordan, Mark (Addex Pharma –200806 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Addex (Group) |
Switzerland |
| Epstein, Barry (Proteomics International 201201 VP Marketing) |
Sales Manager / Marketing Manager |
Proteomics International Pty Ltd. |
Australia |
| Epstein, David R. (Flagship Pioneering 201701– Executive Partner before Novartis –201605 Division Head Pharma LEFT 5/16) |
Partner (venture partner) |
Flagship Pioneering |
United States (USA) |
| Erdman, Chris (CRISPR Therapeutics 201711 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
CRISPR Therapeutics (Group) |
United States (USA) |
| Erdmann, Till (Myelo Therapeutics 201304– Managing Director) |
Managing Director |
Myelo Therapeutics GmbH |
Germany |
| Erdmann, Winfried (Berthold Technologies 201106 European Sales Manager Bioanalytic) |
Sales Manager / Marketing Manager |
Berthold Technologies (Group) |
Germany |
| Ergun, Elcin (Merck (DE) 201409 Head Global Commerical at Merck Serono) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
Germany |
| Erhard, Marcel (AnagnosTec 1998–200912– CSO + co-founder) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
AnagnosTec Gesellschaft für Analytische Biochemie und Diagnostik mbH |
Germany |
| Erhart, Benjamin (High-Tech Gründerfonds 201204 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Eric Fotheringham (Waters 200601 Senior Product Manager) |
Product Manager (personnel) |
Waters (Group) |
Germany |
| Erlen, Hubertus |
n. a. |
Bayer (Group) |
Germany |
| Erlich, Henry (Roche 201103 Roche Molecular Systems Director of Dept of Human Genetics) |
Researcher (industry) |
Children’s Hospital Oakland |
United States (USA) |
| Ermantraut, Eugen (Clondiag 200502 Managing Director) |
Managing Director |
Alere (Group) |
Germany |
| Ernst, Bettina (InterAx Biotech 201901– Non-executive Board Member) |
Board member, non-executive |
InterAx Biotech AG |
Switzerland |
| Ernst, Doreen (Analytik Jena 200809) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Erselius, Jörn R. (Max Planck Innovation Managing Director before Garching Innovation 200311) |
Managing Director |
Max Planck Society for the Advancement of Science |
Germany |
| Erwin, M. Johnston (Eli Lilly 201603 VP Corporate Business Development) |
Business Development Manager / Strategy Manager |
Eli Lilly (Group) |
United States (USA) |
| Eschenfelder, Christina (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
| Escher, Adrian (ESBATech 200205 CFO) |
Chief Financial Officer (CFO) |
Novartis (Group) |
Switzerland |
| Escher, Dominik (ESBATech 200809 CEO) |
Chief Executive Officer (CEO) |
Novartis (Group) |
Switzerland |
| Escher, Klaus |
n. a. |
BASF (Group) |
Germany |
| Esper, Ralph (Eppendorf 201811– Head of Corporate Communications before Hagebau + Hamburger Sparkasse) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
| Esposito, Gloria (Artemis 200705– Project Manager) |
n. a. |
Taconic (Group) |
Germany |
| Essenpreis, Matthias (Roche 201502 CTO of Roche Diagnostics) |
Chief Technology/Technical Officer (CTO) |
Roche (Group) |
United States (USA) |
| Essig, Stuart M. (Wellington Partners 201303– Venture Partner before Integra Life Sciences CEO + Goldman Sachs) |
Venture Partner |
Wellington Partners Venture Capital GmbH |
Germany |
| Essinger, Jacques R. (Symetis 201703 CEO) |
Chief Executive Officer (CEO) |
Boston Scientific (Group) |
Switzerland |
| Esslinger, Christoph (Memo Therapeutics AG 201805 CEO) |
Chief Executive Officer (CEO) |
Memo Therapeutics AG |
Switzerland |
| Etches, Robert J. (Rob) (Crystal Bioscience 201401 CEO) |
Chief Executive Officer (CEO) |
Crystal Bioscience Inc. |
United States (USA) |
| Etzold, Thure (Lion Bioscience 200502–200604 CEO resigned) |
Chief Executive Officer (CEO) |
Genetrix (ES) (Group) |
Germany |
| Eugster, Rudolf (Tecan 200212– CFO) |
Chief Financial Officer (CFO) |
Tecan (Group) |
Switzerland |
| Eul, Wilfried (Evonik 201207 SVP + Head Catalysts Business Line) |
President/Director/Head Business Group/Unit/Division |
Evonik (Group) |
Germany |
| Evans, David (Syngenta 200404) |
n. a. |
Syngenta (Group) |
Switzerland |
| Evans, Richard (EKF Diagnostics 201307– COO before Finance Director) |
Chief Operating Officer (COO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Evans, Thomas G. (Tom) (Vaccitech 201801 CEO before Vical + Novartis + Aeras) |
Chief Executive Officer (CEO) |
Vaccitech Ltd. |
United Kingdom (GB) |
| Evans-Freke, Stephen (Celtic Therapeutics 2007 General Partner + Co-Founder) |
General Partner (venture partner) |
Auven Therapeutics (Group) |
United States (USA) |
| Evenden, Anja (Vego Ltd 201401 Marketing Executive) |
Sales Manager / Marketing Manager |
Vego Ltd. |
United Kingdom (GB) |
| Evens, Andrew (Tufts University 201601 Prof at Tufts Univ School of Medicine + Director of Cancer Center) |
Professor |
Affimed (Group) |
Germany |
| Everson, Lloyd (MolecularHealth 201401 CEO of US division before US Oncology Inc) |
Chief Executive Officer (CEO) |
Molecular Health (Group) |
United States (USA) |
| Evertsz, Carl J. G. (MeVis Medical Solutions 200609–201202 CEO LEAVES 3/12) |
Chief Executive Officer (CEO) |
Varian Medical Systems (Group) |
Germany |
| Evnin, Luke (MPM Capital 201307 Managing Director) |
Managing Director |
MPM Capital (Group) |
United States (USA) |
| Ewert, Markus L. E. (Alentis Therapeutics 201904– CEO before Ablynx+ GE Healthcare + Novartis + Boston Consulting) |
Chief Executive Officer (CEO) |
Alentis Therapeutics AG |
Switzerland |
| Eyber, Klaus U. (Kaye Scholer 200407– Attorney + Partner at Kay Scholer in Ffm before Haarmann Hemmelrath) |
Attorney / Lawyer |
Arnold & Porter Kaye Scholer LLP |
Germany |
| Eylenbosch, Hilde (Biocartis 201611–201904 CCO joined 2013 before Alere + SPD Swiss Precision LEFT 5/19) |
Chief Commercial Officer (CCO) |
Biocartis (Group) |
Belgium |
| Ezickson, Elan (Aveo Pharmaceuticals 201112 CBO) |
Chief Business Officer (CBO) |
Aveo Pharmaceuticals Inc. |
United States (USA) |
| Fabro, Scott (Evolva 20107– CCO before Sweet Harvest Foods + ACH Foods + Kerry + Cargill) |
Chief Commercial Officer (CCO) |
Evolva (Group) |
Switzerland |
| Fackler, Thomas |
n. a. |
Fraunhofer (Group) |
Germany |
| Faeh, Urban (Bruker 201001– President Bruker Optics division joined Bruker 1998 as sales manager) |
President/Director/Head Business Group/Unit/Division |
Bruker BioSciences (Group) |
|
| Fafflock, Heike (Bremen 201005– Innovation Manager Health before B.I.T. + hkk) |
n. a. |
Bremen (govt region) |
Germany |
| Fagerberg, Jan (Micromet 200911 SVP + CMO) |
Chief Medical Officer (CMO) |
Amgen (Group) |
Germany |
| Fahr, Anne-Marie (Labor Limbach 200909 Head Microbiology) |
Laboratory Manager (industry) |
Labor Limbach (Group) |
Germany |
| Fahrenberg, Jens (Karlsruhe Institute of Technology 201307 Head of Innovation Management Office) |
IP Manager |
Karlsruhe Institute of Technology (KIT) |
Germany |
| Fairey, Bill (Actelion 201311 President of Actelion Pharmaceuticals US) |
President/Director/Head Business Group/Unit/Division |
Johnson & Johnson (JnJ) (Group) |
United States (USA) |
| Fakih, Sarah (MorphoSys 201904– Head CorpComms + IR before Qiagen Director IR joined Qiagen 2009) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
| Falcenberg, Matthias (Forbion 201604– Analyst at Munich Office before at MPI of Biochemistry) |
Analyst (Financial / Industry) |
Forbion Capital Partners (NL) |
Germany |
| Falch, Siegfried (JEOL 201002 Managing Director JEOL (Germany) GmbH) |
Managing Director |
JEOL (Group) |
Germany |
| Falchuk, Jason (BioBridges 201709 President + Founding Partner) |
President/Director/Head Business Group/Unit/Division |
Adecco (Group) |
United States (USA) |
| Falk, Ursula (Dr Falk Pharma 201403 Managing Director) |
Managing Director |
Dr. Falk Pharma GmbH |
Germany |
| Falken, Ulrich (Analyticon Biotechnologies 2007 COO) |
Chief Operating Officer (COO) |
Analyticon Biotechnologies AG |
Germany |
| Fallen, Karen (Lonza 201308 VP Licensing + Technology Lonza Development Services) |
Business Development Manager / Strategy Manager |
Lonza Group (Group) |
Switzerland |
| Fambrough, Douglas M. (Dicerna Pharmaceuticals 201711 CEO) |
Chief Executive Officer (CEO) |
Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) |
United States (USA) |
| Faraco, Vincenza (University of Naples Federico II 201405) |
Researcher (university / research institute) |
University of Naples Federico II |
Italy |
| Farhangi, Sonja (Stratec 201110 Stratec Molecular GmbH Marketing + Public Relations) |
Sales Manager / Marketing Manager |
Stratec (Group) |
Germany |
| Farinelli, Laurent (Fasteris 200901 CEO + co-founder |
Chief Executive Officer (CEO) |
Fasteris S.A. |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 14 15 16 ... 65 66 67 
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 600x60px](/banner/iito-20181119-600-060-lse-life-sciences-europe-com.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
